Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 8.01, 9.01 · 8-K

BioCardia, Inc.

BCDANASDAQEQUITYCurrent

Other Events

Item 8.01 Other Events. On September 10, 2026, BioCardia, Inc. issued a press release announcing that Peter Altman, Ph. D., President and Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference. The conference will be held at the Lotte New York Palace Hotel in New York City, September 14-16, 2026.…

Filed Sep 10, 2026Accepted Sep 10, 2026, 8:30 AM EDTCIK 925741Accession 0001437749-26-030023
Share

Company context

Current securities

Historical securities (1)

Recent company filings

  1. Other EventsSep 23, 2026
  2. Other EventsSep 21, 2026
  3. Regulation FD DisclosureAug 24, 2026
  4. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingAug 21, 2026
  5. Results of Operations and Financial ConditionAug 12, 2026

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. On September 10, 2026, BioCardia, Inc. issued a press release announcing that Peter Altman, Ph. D., President and Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference. The conference will be held at the Lotte New York Palace Hotel in New York City, September 14-16, 2026. A copy of the press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K. The information furnished pursuant to this Item 8.01, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section, nor shall it be deemed to be incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly set forth by specific reference in such filing.